Omega Therapeutics Inc (OMGA)
1.055
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 10:26
Omega Therapeutics Price: 1.055 for Nov. 5, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 04, 2024 | 1.11 | 1.12 | 1.055 | 1.055 | 220973.0 |
Nov 01, 2024 | 1.17 | 1.220 | 1.10 | 1.11 | 244637.0 |
Oct 31, 2024 | 1.26 | 1.30 | 1.15 | 1.16 | 329391.0 |
Oct 30, 2024 | 1.21 | 1.35 | 1.21 | 1.27 | 269180.0 |
Oct 29, 2024 | 1.26 | 1.30 | 1.190 | 1.24 | 263931.0 |
Oct 28, 2024 | 1.37 | 1.41 | 1.26 | 1.27 | 405353.0 |
Oct 25, 2024 | 1.48 | 1.51 | 1.36 | 1.39 | 305373.0 |
Oct 24, 2024 | 1.34 | 1.48 | 1.29 | 1.45 | 495509.0 |
Oct 23, 2024 | 1.41 | 1.69 | 1.19 | 1.34 | 1.943M |
Oct 22, 2024 | 1.07 | 1.45 | 1.01 | 1.39 | 1.121M |
Oct 21, 2024 | 1.08 | 1.08 | 1.04 | 1.07 | 116409.0 |
Oct 18, 2024 | 1.07 | 1.15 | 1.02 | 1.06 | 368854.0 |
Oct 17, 2024 | 0.89 | 1.06 | 0.89 | 1.04 | 546760.0 |
Oct 16, 2024 | 0.91 | 0.9225 | 0.8952 | 0.9047 | 225220.0 |
Oct 15, 2024 | 0.95 | 0.965 | 0.894 | 0.894 | 306908.0 |
Oct 14, 2024 | 1.01 | 1.01 | 0.9417 | 0.9516 | 294562.0 |
Oct 11, 2024 | 0.97 | 0.995 | 0.94 | 0.96 | 252117.0 |
Oct 10, 2024 | 1.07 | 1.07 | 0.9881 | 0.9883 | 323513.0 |
Oct 09, 2024 | 1.07 | 1.12 | 1.06 | 1.07 | 167124.0 |
Oct 08, 2024 | 1.07 | 1.12 | 1.07 | 1.07 | 147333.0 |
Oct 07, 2024 | 1.11 | 1.13 | 1.07 | 1.07 | 268873.0 |
Oct 04, 2024 | 1.14 | 1.16 | 1.12 | 1.12 | 146966.0 |
Oct 03, 2024 | 1.12 | 1.276 | 1.11 | 1.14 | 314800.0 |
Oct 02, 2024 | 1.20 | 1.20 | 1.070 | 1.09 | 380184.0 |
Oct 01, 2024 | 1.25 | 1.274 | 1.20 | 1.20 | 123468.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.894
Minimum
Oct 15 2024
29.38
Maximum
Oct 29 2021
6.576
Average
4.81
Median
Sep 02 2022
Price Benchmarks
Moderna Inc | 53.27 |
NovaBay Pharmaceuticals Inc | 0.76 |
Palatin Technologies Inc | 1.22 |
iBio Inc | 2.705 |
Theriva Biologics Inc | 2.06 |
Price Related Metrics
PS Ratio | 9.215 |
Price to Book Value | 2.216 |
Earnings Yield | -134.6% |
Market Cap | 58.19M |